| Mrs Nicole Jacobi, MD | |
|
11850 Blackfoot St Nw Ste 100, Coon Rapids, MN 55433-2774 | |
| (763) 712-2100 | |
| (763) 712-2190 |
| Full Name | Mrs Nicole Jacobi |
|---|---|
| Gender | Female |
| Speciality | Hematology/oncology |
| Experience | 31 Years |
| Location | 11850 Blackfoot St Nw Ste 100, Coon Rapids, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780041301 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 60242 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Abbott Northwestern Hospital | Minneapolis, MN | Hospital |
| Mercy Hospital | Coon rapids, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Minnesota Oncology Hematology, Pa | 6709799752 | 104 |
News Archive
Spirogen Limited and Celtic Therapeutics Holdings LP announced today the commencement of a Phase II clinical trial of SG2000 in ovarian cancer. The trial is being sponsored by the National Cancer Institute of the USA, and is now actively recruiting patients for treatment.
Cervical cancer is the second most common cause of cancer-related death worldwide, with almost 300,000 deaths occurring each year. More than 80 percent of these deaths occur in developing nations.
Rising food prices could force 64 million Asians into extreme poverty and damage the region's economic growth this year, according to a report released on Tuesday from the Asian Development Bank, Agence France-Presse reports.
Medivir AB, the research-based specialty pharmaceutical company focused on infectious diseases, announces that its unique cold sore product Xerclear, which Medivir developed in-house, is now being launched for over-the-counter (OTC) use by its partner GlaxoSmithKline (GSK) in Europe.
Medicago USA Inc., a wholly owned subsidiary of Medicago Inc., a clinical-stage biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced that it has been awarded a $21 Million grant from the Defense Advanced Research Projects Agency, Broad Agency Announcement, Defense Sciences Research & Technology to demonstrate the scalable manufacturing of its plant-expressed VLP vaccines in the U.S.A. under a Technology Investment Agreement.
› Verified 1 days ago
| Entity Name | Minnesota Oncology Hematology, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528035995 PECOS PAC ID: 6709799752 Enrollment ID: O20031106000626 |
News Archive
Spirogen Limited and Celtic Therapeutics Holdings LP announced today the commencement of a Phase II clinical trial of SG2000 in ovarian cancer. The trial is being sponsored by the National Cancer Institute of the USA, and is now actively recruiting patients for treatment.
Cervical cancer is the second most common cause of cancer-related death worldwide, with almost 300,000 deaths occurring each year. More than 80 percent of these deaths occur in developing nations.
Rising food prices could force 64 million Asians into extreme poverty and damage the region's economic growth this year, according to a report released on Tuesday from the Asian Development Bank, Agence France-Presse reports.
Medivir AB, the research-based specialty pharmaceutical company focused on infectious diseases, announces that its unique cold sore product Xerclear, which Medivir developed in-house, is now being launched for over-the-counter (OTC) use by its partner GlaxoSmithKline (GSK) in Europe.
Medicago USA Inc., a wholly owned subsidiary of Medicago Inc., a clinical-stage biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced that it has been awarded a $21 Million grant from the Defense Advanced Research Projects Agency, Broad Agency Announcement, Defense Sciences Research & Technology to demonstrate the scalable manufacturing of its plant-expressed VLP vaccines in the U.S.A. under a Technology Investment Agreement.
› Verified 1 days ago
| Entity Name | Allina Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295272342 PECOS PAC ID: 4587573613 Enrollment ID: O20040319000460 |
News Archive
Spirogen Limited and Celtic Therapeutics Holdings LP announced today the commencement of a Phase II clinical trial of SG2000 in ovarian cancer. The trial is being sponsored by the National Cancer Institute of the USA, and is now actively recruiting patients for treatment.
Cervical cancer is the second most common cause of cancer-related death worldwide, with almost 300,000 deaths occurring each year. More than 80 percent of these deaths occur in developing nations.
Rising food prices could force 64 million Asians into extreme poverty and damage the region's economic growth this year, according to a report released on Tuesday from the Asian Development Bank, Agence France-Presse reports.
Medivir AB, the research-based specialty pharmaceutical company focused on infectious diseases, announces that its unique cold sore product Xerclear, which Medivir developed in-house, is now being launched for over-the-counter (OTC) use by its partner GlaxoSmithKline (GSK) in Europe.
Medicago USA Inc., a wholly owned subsidiary of Medicago Inc., a clinical-stage biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced that it has been awarded a $21 Million grant from the Defense Advanced Research Projects Agency, Broad Agency Announcement, Defense Sciences Research & Technology to demonstrate the scalable manufacturing of its plant-expressed VLP vaccines in the U.S.A. under a Technology Investment Agreement.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Nicole Jacobi, MD 2550 University Ave W Ste 110n, Saint Paul, MN 55114-8693 Ph: (651) 602-5309 | Mrs Nicole Jacobi, MD 11850 Blackfoot St Nw Ste 100, Coon Rapids, MN 55433-2774 Ph: (763) 712-2100 |
News Archive
Spirogen Limited and Celtic Therapeutics Holdings LP announced today the commencement of a Phase II clinical trial of SG2000 in ovarian cancer. The trial is being sponsored by the National Cancer Institute of the USA, and is now actively recruiting patients for treatment.
Cervical cancer is the second most common cause of cancer-related death worldwide, with almost 300,000 deaths occurring each year. More than 80 percent of these deaths occur in developing nations.
Rising food prices could force 64 million Asians into extreme poverty and damage the region's economic growth this year, according to a report released on Tuesday from the Asian Development Bank, Agence France-Presse reports.
Medivir AB, the research-based specialty pharmaceutical company focused on infectious diseases, announces that its unique cold sore product Xerclear, which Medivir developed in-house, is now being launched for over-the-counter (OTC) use by its partner GlaxoSmithKline (GSK) in Europe.
Medicago USA Inc., a wholly owned subsidiary of Medicago Inc., a clinical-stage biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced that it has been awarded a $21 Million grant from the Defense Advanced Research Projects Agency, Broad Agency Announcement, Defense Sciences Research & Technology to demonstrate the scalable manufacturing of its plant-expressed VLP vaccines in the U.S.A. under a Technology Investment Agreement.
› Verified 1 days ago
Dr. Jaya Bhattarai, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4050 Coon Rapids Blvd Nw, Coon Rapids, MN 55433 Phone: 763-236-6000 | |
Zongyu J Chen, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 9145 Springbrook Dr, #200, Coon Rapids, MN 55433 Phone: 612-871-1145 Fax: 612-870-5491 | |
Amber Galarowicz, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4050 Coon Rapids Blvd Nw, Coon Rapids, MN 55433 Phone: 763-236-6000 | |
Evan L Domeyer, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3960 Coon Rapids Blvd Nw, 100, Coon Rapids, MN 55433 Phone: 763-236-9400 Fax: 763-236-9423 | |
Natalia Yazigi, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 9055 Springbrook Dr Nw, Coon Rapids, MN 55433 Phone: 763-780-9155 | |
Linda Benjamin Soucie, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3960 Coon Rapids Blvd Nw, 100, Coon Rapids, MN 55433 Phone: 763-236-9400 Fax: 763-236-9423 | |
Wendoly R Slattery, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 9055 Springbrook Dr Nw, Coon Rapids, MN 55433 Phone: 763-780-9155 |